Literature DB >> 25587197

Plasma capric acid concentrations in healthy subjects determined by high-performance liquid chromatography.

Rojeet Shrestha1, Shu-Ping Hui2, Hiromitsu Imai3, Satoru Hashimoto4, Naoto Uemura4, Seiji Takeda1, Hirotoshi Fuda1, Akira Suzuki5, Satoshi Yamaguchi5, Ken-Ichi Hirano5, Hitoshi Chiba1.   

Abstract

BACKGROUND: Capric acid (FA10:0, decanoic acid) is a medium-chain fatty acid abundant in tropical oils such as coconut oil, whereas small amounts are present in milk of goat, cow, and human. Orally ingested FA10:0 is transported to the liver and quickly burnt within it. Only few reports are available for FA10:0 concentrations in human plasma.
METHODS: Fasting (n = 5, male/female = 3/2, age 31 ± 9.3 years old) and non-fasting (n = 106, male/female = 44/62, age 21.9 ± 3.2 years old) blood samples were collected from apparently healthy Japanese volunteers. The total FA10:0 in the plasma were measured by high-performance liquid chromatography after derivatization with 2-nitrophenylhydrazine followed by UV detection.
RESULTS: Inter and intra-assay coefficient of variation of FA10:0 assay at three different concentrations ranged in 1.7-3.9 and 1.3-5.4%, respectively, with an analytical recovery of 95.2-104.0%. FA10:0 concentration was below detection limit (0.1 µmol/L) in each fasting human plasma. FA10:0 was not detected in 50 (47.2%) of 106 non-fasting blood samples, while 29 (27.4%) plasma samples contained FA10:0 less than or equal to 0.5 µmol/L (0.4 ± 0.1), and 27 (25.5%) contained it at more than 0.5 µmol/L (0.9 ± 0.3).
CONCLUSION: A half of the non-fasting plasma samples contained detectable FA10:0. This simple, precise, and accurate high-performance liquid chromatography method might be useful for monitoring plasma FA10:0 during medium-chain triglycerides therapy.
© The Author(s) 2015.

Entities:  

Keywords:  High-performance liquid chromatography; medium-chain triglycerides; plasma capric acid

Mesh:

Substances:

Year:  2015        PMID: 25587197     DOI: 10.1177/0004563215569081

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis.

Authors:  Grzegorz Godlewski; Resat Cinar; Nathan J Coffey; Jie Liu; Tony Jourdan; Bani Mukhopadhyay; Lee Chedester; Ziyi Liu; Douglas Osei-Hyiaman; Malliga R Iyer; Joshua K Park; Roy G Smith; Hiroshi Iwakura; George Kunos
Journal:  Cell Metab       Date:  2019-05-16       Impact factor: 27.287

2.  A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease.

Authors:  Keisuke Miki; Seigo Kitada; Mari Miki; Shu-Ping Hui; Rojeet Shrestha; Kenji Yoshimura; Kazuyuki Tsujino; Hiroyuki Kagawa; Yohei Oshitani; Hiroshi Kida; Ryoji Maekura; Kenji Kangawa
Journal:  J Physiol Sci       Date:  2019-10-08       Impact factor: 2.781

3.  Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84.

Authors:  Zobaer Al Mahmud; Laura Jenkins; Trond Ulven; Frédéric Labéguère; Romain Gosmini; Steve De Vos; Brian D Hudson; Irina G Tikhonova; Graeme Milligan
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

4.  Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder.

Authors:  Ming Li; Ken-Ichi Hirano; Yoshihiko Ikeda; Masahiro Higashi; Chikako Hashimoto; Bo Zhang; Junji Kozawa; Koichiro Sugimura; Hideyuki Miyauchi; Akira Suzuki; Yasuhiro Hara; Atsuko Takagi; Yasuyuki Ikeda; Kazuhiro Kobayashi; Yoshiaki Futsukaichi; Nobuhiro Zaima; Satoshi Yamaguchi; Rojeet Shrestha; Hiroshi Nakamura; Katsuhiro Kawaguchi; Eiryu Sai; Shu-Ping Hui; Yusuke Nakano; Akinori Sawamura; Tohru Inaba; Yasuhiko Sakata; Yoko Yasui; Yasuyuki Nagasawa; Shintaro Kinugawa; Kazunori Shimada; Sohsuke Yamada; Hiroyuki Hao; Daisaku Nakatani; Tomomi Ide; Tetsuya Amano; Hiroaki Naito; Hironori Nagasaka; Kunihisa Kobayashi
Journal:  Orphanet J Rare Dis       Date:  2019-06-11       Impact factor: 4.123

5.  Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84.

Authors:  Anna Peters; Philipp Rabe; Petra Krumbholz; Hermann Kalwa; Robert Kraft; Torsten Schöneberg; Claudia Stäubert
Journal:  Cell Commun Signal       Date:  2020-02-26       Impact factor: 5.712

6.  Comparison of dimension reduction methods on fatty acids food source study.

Authors:  Yifan Chen; Yusuke Miura; Toshihiro Sakurai; Zhen Chen; Rojeet Shrestha; Sota Kato; Emiko Okada; Shigekazu Ukawa; Takafumi Nakagawa; Koshi Nakamura; Akiko Tamakoshi; Hitoshi Chiba; Hideyuki Imai; Hiroyuki Minami; Masahiro Mizuta; Shu-Ping Hui
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.